Founded in 1876, Eli Lilly was founded by Colonel Eli Lilly, who is committed to producing high-quality medicines that meet actual needs. More than a century later, Lilly continues to carry on this tradition as it continues to seek to achieve the goal of making life better for the individuals, communities and the world around it.

Historical inheritance and values ​​are the basis of the commitments made by Lilly. Lilly adheres to the belief of care and exploration, and is committed to the research and development of innovative drugs to make people all over the world live a better life. Globally, Eli Lilly’s employees continue to work to invent and bring life-changing medicines for those in need, raise awareness and management of diseases, and give back to relevant communities through charity and volunteer activities.

Eli Lilly's relationship with China can be traced back to the early twentieth century. Lilly came to China in 1918 and set up its first overseas representative office in Shanghai, thus taking the pace of globalization. After many ups and downs, Lilly returned to China in 1993. For more than 20 years, Eli Lilly has focused on expanding its business in China in accordance with the concept of "rooted in China and benefiting China". Eli Lilly has about 3,400 employees in China, and its company's business has now penetrated into nearly 400 cities in China.

Eli Lilly established Eli Lilly Suzhou Pharmaceutical Co., Ltd. in Suzhou, which is its wholly-owned pharmaceutical company in China. Adhere to continuous innovation and high-quality manufacturing, as long as medicines with the red Eli Lilly logo represent high quality. Eli Lilly increased its capital and expanded its production base in China twice within five years, practicing its consistent commitment to China, demonstrating Eli Lilly's firm confidence in this global large-scale pharmaceutical market in the future.

In order to effectively bridge China's current innovation ecological environment, better leverage China's current favorable policy environment, promote new drug development faster, and bring new breakthrough drugs to global and Chinese patients, Eli Lilly China Innovation Cooperation Center brings the Such a mission came into being in 2018.

Eli Lilly’s business principles in China are consistent with the principles globally, fully reflecting the creed of “integrity first, pursuit of excellence, and putting people first”. Eli Lilly’s purpose is to become an honest Chinese corporate citizen, and to provide high-quality medicines to the Chinese people by “rooting China and benefiting China”, saving patients’ lives and improving the quality of life of the public.

Eli Lilly is committed to becoming the main strategic partner in China's healthcare field, with a far-sighted vision and giving back to society. Over the past 20 years since returning to China, Eli Lilly has devoted great enthusiasm to the development of public health and social assistance activities. At the same time, Eli Lilly has carried out various forms of mass education activities to convey disease information, popularize health knowledge, and improve the public's quality of life.